Statistics from Altmetric.com
Apart from Prader-Willi syndrome, which is a well delineated imprinting disorder of the 15q11-q12 region, other chromosome anomalies have been described in a small number of patients with features reminiscent of Prader-Willi syndrome, including hypotonia, progressive obesity, small extremities, and delayed developmental milestones. Among these chromosome anomalies are some cases of interstitial deletion of chromosome 6q1–5 and haploinsufficiency of the SIM1 gene (6q16.2) has been proposed as a candidate gene for obesity.6 Here, we report a fifth case of Prader-Willi-like phenotype associated with an interstitial chromosome 6q deletion (6q16.1-q21) detected only by high resolution banding techniques. This suggests that a subgroup of patients with features reminiscent of Prader-Willi syndrome and an interstitial deletion of chromosome 6q16.2 could be delineated.
The proband was the only child of a 27 year old mother and a 32 year old father. Intrauterine growth retardation, oligohydramnios, and a left club foot were noted during the third trimester of pregnancy. He was born at term after a normal delivery. His growth parameters were weight 2350 g (−2.5 SD), length 47 cm (−1.5 SD), and OFC 33 cm (−1.5 SD). He was described as floppy and had feeding difficulties in early infancy. He sat at the age of 2 years, walked at 3½12 years, and had no speech when we first saw him aged 5 years. Excessive weight gain began at 3 years, with a big appetite and food seeking behaviour. There were no sleep disturbances. His behaviour was hyperactive, with a short attention span and intolerance to frustration. Interaction with other children was non-existent.
At physical examination, weight was +5.5 SD, height was −1 SD, and OFC was +2.5 SD. He had generalised obesity, slightly dysmorphic features including a square and flat face, a large forehead with a protruding metopic ridge, small palpebral fissures, mild strabismus, a thin nose, and thin lips (fig 1). The ears were low set with very small lobes. The hands and feet were small with low implanted thumbs, the external genitalia were normal, and a dry skin with livedo was noted. No malformations were found. Clumsiness and a wide based gait were noted at neurological examination. Metabolic screening and fragile X studies were normal, as was a cerebral MRI. Bone age was 3½12 years at the age of 5. Psychometric evaluation showed performance at a 2½12 year level (DQ = 50).
Cytogenetic and molecular analyses
In order to rule out Prader-Willi syndrome, a methylation assay of the SNRPN gene and a FISH study with the SNRPN probe were performed. Both analyses showed normal results, as well as standard cytogenetic and telomere analyses using microsatellite polymorphic markers. However, high resolution banding analysis performed on cultured peripheral blood lymphocytes using R and G banding techniques showed a 46,XY,del(6)(q16.1q21) karyotype (fig 2A). Karyotypes of the parents were normal. Comparative genomic hybridisation study confirmed the deletion (fig 2B). Molecular studies using microsatellite polymorphic markers D6S1709, D6S1580, and D6S447 (6q16.3-q21) were fully informative and showed that the 6q deletion was paternal in origin. In addition, molecular studies using an intragenic microsatellite polymorphic marker within the SIM1 gene (primers 5`-GGCTGGCTCCAACTCGG-3` and reverse 5`-GATCAGCAGGCAGGAGAG-3`) were fully informative and showed that the SIM1 gene was deleted (fig 2C).
Here we report on the fifth case of chromosome 6q deletion in association with a Prader-Willi-like phenotype. A review of five patients with an interstitial chromosome 6q deletion and a Prader-Willi-like phenotype showed that they all shared the following features with Prader-Willi syndrome patients: obesity, hypotonia, short extremities, and developmental delay.2–5 However, there are also distinct differences. For example, excessive appetite was seen in only two patients and cardiac (bicuspid aortic valve, aortic stenosis, right branch block) as well as neurological abnormalities (polygyria, leucomalacia, seizures, hearing loss, Arnold-Chiari malformation) were found in 2/5 and 3/5 patients, respectively. These differences are summarised in table 1.
Interestingly, four out of five patients described have a 6q16.2 deletion (fig 3). This suggests that the 6q16.2 subband could be regarded as a region of interest for obesity related genes. In addition, a balanced translocation between chromosomes 1p22.1 and 6q16.2 has been reported in a patient with profound obesity.6 The authors cloned and sequenced both translocation breakpoints. While the translocation did not appear to affect any transcription unit on 1p22.1, it disrupted the SIM1 gene on 6q16.2. They hypothesised that haploinsufficiency of SIM1, possibly acting upstream or downstream of the melanocortin 4 receptor in the paraventricular nuclei of the hypothalamus, could be responsible for obesity in their subject. Indeed, it has been shown in the mouse that the Sim1 gene is expressed in the central nervous system where it has an important role in the development of the supraoptic and the paraventricular nuclei of the hypothalamus.7 In addition, there is good evidence from anatomical and pharmacological studies that these nuclei are involved in the regulation of body weight as these neurones express the melanocortin-4 receptor8 and appear to be a target of alpha melanocyte stimulating hormone, which inhibits food intake.9 Interestingly, the SIM1 gene is also deleted in our patient. Therefore, this observation provides further support for the hypothesis that haploinsufficiency of the SIM1 gene might be responsible for the obesity observed in our patient.
There is also some evidence in published reports that other chromosome 6q loci might carry obesity related genes, namely: (1) a patient reported by Stein et al4 with a Prader-Willi-like phenotype and a deletion distal to the subband 6q16.2 as well as patients with distal deletion of chromosome 6q and obesity alone10; (2) the observation of patients with 6q duplication and obesity11,12; and (3) the discovery of a major locus for fasting insulin concentrations and insulin resistance with strong pleiotropic effects on obesity related phenotypes on distal chromosome 6q13 (fig 3).
Finally, there is good evidence that some chromosome 6q genes are submitted to genomic imprinting (http://www.geneimprint.com). For example, transient neonatal diabetes mellitus is associated with paternal uniparental disomy for chromosome 6 or paternal duplication of chromosome 6q24.14 In our report, the deletion was of paternal origin, as was the duplication of chromosome 6q24.3-q27 in the patient reported by Smith et al.11 However, the relationship between imprinting and obesity in chromosome 6q deletion remains unknown. Further molecular studies of similar cases might help to resolve the possible causal relationship between imprinting and obesity.
In conclusion, this observation suggests that in patients with a Prader-Willi phenotype and a normal cytogenetic/molecular study of the 15q11-q12 region, deletion of the 6q16.2 region and the SIM1 gene in particular should be looked for.
We thank M Pick and C Ozilou for their excellent technical work and Y Deris for his photographic assistance.
Please note that there is an error in the reverse primer sequence used for amplification of the intragenic microsatellite polymorphic marker of the SIM1 gene.
The correct sequence is shown here:
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.